Evidence map›Paper›PMID 40009842›Full record

ArticleInteractive journal of medical research2025

Current Status and Future Directions of Ferroptosis Research in Breast Cancer: Bibliometric Analysis.

Jia-Yuan Luo, Yu-Long Deng, Shang-Yi Lu, Si-Yan Chen, Rong-Quan He, Di-Yuan Qin, Bang-Teng Chi, Gang Chen, Xia Yang, Wei Peng

Abstract read
In one paragraph

Article in Interactive journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Metabolic Regulation of Ferroptosis in Breast Cancer.International journal of molecular sciences · 2025
    Review
  6. Review
  7. The selenium paradox friend or foe in breast cancer?Annals of medicine and surgery (2012) · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jia-Yuan Luo *Department of Pathology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.ORCID https://orcid.org/0000-0003-4712-5217
Yu-Long Deng *Department of Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.ORCID https://orcid.org/0009-0005-5314-2576
Shang-Yi LuDepartment of Hepatological and Gland Surgery, Wuzhou Gongren Hospital/The Seventh Affiliated Hospital of Guangxi Medical University, Wuzhou, China.ORCID https://orcid.org/0009-0004-4867-0908
Si-Yan ChenDay Chemotherapy Center, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.ORCID https://orcid.org/0009-0002-1720-8660
Rong-Quan HeDepartment of Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.ORCID https://orcid.org/0000-0002-7752-2080
Di-Yuan QinDepartment of Computer Science and Technology, School of Computer and Electronic Information, Guangxi University, Nanning, China.ORCID https://orcid.org/0009-0003-3214-4762
Bang-Teng ChiDepartment of Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.ORCID https://orcid.org/0009-0000-5504-5589
Gang ChenDepartment of Pathology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.ORCID https://orcid.org/0000-0003-2402-2987
Xia YangDepartment of Pathology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.ORCID https://orcid.org/0009-0008-8590-8734
Wei PengDepartment of Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.ORCID https://orcid.org/0009-0007-3492-0875

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFerroptosis, as a novel modality of cell death, holds significant potential in elucidating the pathogenesis and advancing therapeutic strategies for breast cancer.

objectiveThis study aims to comprehensively analyze current ferroptosis research and future trends, guiding breast cancer research advancements and innovative treatment strategies.

methodsThis research used the R package Bibliometrix (Department of Economic and Statistical Sciences at the University of Naples Federico II), VOSviewer (Centre for Science and Technology Studies at Leiden University), and CiteSpace (Drexel University's College of Information Science and Technology), to conduct a bibliometric analysis of 387 papers on breast cancer and ferroptosis from the Web of Science Core Collection. The analysis covers authors, institutions, journals, countries or regions, publication volumes, citations, and keywords.

resultsThe number of publications related to this field has surged annually, with China and the United States collaborating closely and leading in output. Sun Yat-sen University stands out among the institutions, while the journal Frontiers in Oncology and the author Efferth T contribute significantly to the field. Highly cited papers within the domain primarily focus on the induction of ferroptosis, protein regulation, and comparisons with other modes of cell death, providing a foundation for breast cancer treatment. Keyword analysis highlights the maturity of glutathione peroxidase 4-related research, with breast cancer subtypes emerging as motor themes and the tumor microenvironment, immunotherapy, and prognostic models identified as basic themes. Furthermore, the application of nanoparticles serves as an additional complement to the basic themes.

conclusionsThe current research status in the field of ferroptosis and breast cancer primarily focuses on the exploration of relevant theoretical mechanisms, whereas future trends and mechanisms emphasize the investigation of therapeutic strategies, particularly the clinical application of immunotherapy related to the tumor microenvironment. Nanotherapy has demonstrated significant clinical potential in this domain. Future research directions should deepen the exploration in this field and accelerate the clinical translation of research findings to provide new insights and directions for the innovation and development of breast cancer treatment strategies.

Indexed as

advancementsbibliographybibliometricbibliometric analysisbreast cancerbreast carcinomacancer studiesChinadisparitiesferroptosisforecastmalignancymammary cancerreviewstrategytreatmenttreatment strategiestrendsUnited StatesVOSviewer

Identifiers

PMID40009842
PMCPMC11904379

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.